Facebook Linkedin RSS Twitter Youtube
Home 2024

Roche company

Lonza to Buy Genentech’s Vacaville, CA Biologics Manufacturing Site for $1.2B
Bioprocessing

Lonza to Buy Genentech’s Vacaville, CA Biologics Manufacturing Site for $1.2B

With $86M Oversubscribed Public Offering, Absci Eyes 2025 IND for Lead Candidate
Artificial Intelligence

With $86M Oversubscribed Public Offering, Absci Eyes 2025 IND for Lead Candidate

GenEdit Tackles “Delivery, Delivery, Delivery” with Up-to-$644M Genentech Collaboration
Drug Discovery

GenEdit Tackles “Delivery, Delivery, Delivery” with Up-to-$644M Genentech Collaboration

Top 25 Biotech Companies of 2024
A-Lists

Top 25 Biotech Companies of 2024

StockWatch: Analysts Weigh Obesity Drug Market Pegged at $100B by 2030
Drug Discovery

StockWatch: Analysts Weigh Obesity Drug Market Pegged at $100B by 2030

Roche to Acquire Carmot Therapeutics for Up to $3.1B
Drug Discovery

Roche to Acquire Carmot Therapeutics for Up to $3.1B

AbbVie to Acquire ImmunoGen for $10.1B, Expanding Cancer Franchise
Cancer

AbbVie to Acquire ImmunoGen for $10.1B, Expanding Cancer Franchise

Roche to Acquire Telavant for Up-to-$7.25B, Adding IBD Antibody
Drug Discovery

Roche to Acquire Telavant for Up-to-$7.25B, Adding IBD Antibody

StockWatch: Insilico CEO Breaks Down Exelixis Deal
Artificial Intelligence

StockWatch: Insilico CEO Breaks Down Exelixis Deal

Samsung Biologics Inks Extended Deals Worth $897 Million with Pfizer
Bioprocessing

Samsung Biologics Inks Extended Deals Worth $897 Million with Pfizer

123...55Page 2 of 55
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.